Recent Advances in Targeted Drug Delivery Strategy for Enhancing Oncotherapy
Pharmaceutics · 29.08.2023 · 15 (9) · 2233
DOI: 10.3390/pharmaceutics15092233 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 29.08.2023. Verfasst von Jianmin Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science and Technology & Institute of Materia Medica, Xinjiang University, Urumqi 830017, China. Die Arbeit wurde bisher 287-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, Key research and development program in Xinjiang Uygur Autonomous Region, the Project of Institute of Respiratory Diseases, Xiamen Medical College.
Abstract (Originalsprache)
Targeted drug delivery is a precise and effective strategy in oncotherapy that can accurately deliver drugs to tumor cells or tissues to enhance their therapeutic effect and, meanwhile, weaken their undesirable side effects on normal cells or tissues. In this research field, a large number of researchers have achieved significant breakthroughs and advances in oncotherapy. Typically, nanocarriers as a promising drug delivery strategy can effectively deliver drugs to the tumor site through enhanced permeability and retention (EPR) effect-mediated passive targeting and various types of receptor-mediated active targeting, respectively. Herein, we review recent targeted drug delivery strategies and technologies for enhancing oncotherapy. In addition, we also review two mainstream drug delivery strategies, passive and active targeting, based on various nanocarriers for enhancing tumor therapy. Meanwhile, a comparison and combination of passive and active targeting are also carried out. Furthermore, we discuss the associated challenges of passive and active targeted drug delivery strategies and the prospects for further study.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Life Science and Technology & Institute of Materia Medica, Xinjiang University, Urumqi 830017, China.
- Xiamen Key Laboratory of Traditional Chinese Bio-Engineering, Xiamen Medical College, Xiamen 361021, China.
- College of Materials, Xiamen University, Xiamen 361002, China.
ORCID-Profile: Jinyao Li
Förderung
- Fundamental Research Funds for the Central Universities
- Key research and development program in Xinjiang Uygur Autonomous Region
- the Project of Institute of Respiratory Diseases, Xiamen Medical College
- Autonomous Region universities’ basic research funds, research projects-cultivation projects
- Opening Project of Xinjiang Uyghur drug Key Laboratory
- Project of Institute of Respiratory Diseases, Xiamen Medical College
Zitieren
APA
Li, J., Wang, Q., Xia, G., Adilijiang, N., Li, Y., Hou, Z., Fan, Z., & Li, J. (2023). Recent Advances in Targeted Drug Delivery Strategy for Enhancing Oncotherapy. Pharmaceutics, 15(9), 2233. https://doi.org/10.3390/pharmaceutics15092233
Vancouver
Li J, Wang Q, Xia G, Adilijiang N, Li Y, Hou Z, et al. Recent Advances in Targeted Drug Delivery Strategy for Enhancing Oncotherapy. Pharmaceutics. 2023;15(9):2233. doi:10.3390/pharmaceutics15092233
BibTeX
@article{Li2023,
author = {Li, Jianmin and Wang, Qingluo and Xia, Guoyu and Adilijiang, Nigela and Li, Ying and Hou, Zhenqing and Fan, Zhongxiong and Li, Jinyao},
title = {Recent Advances in Targeted Drug Delivery Strategy for Enhancing Oncotherapy},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {9},
pages = {2233},
doi = {10.3390/pharmaceutics15092233}
}
EUVIMED